Physician profile
Omar Baez
NPI 1427348978
$11,086.37
in general payments reported to CMS, 2019-2025
65 companies · $1,942 in 2025
The $1,942 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $677 · 2020: $1,047 · 2021: $1,451 · 2022: $1,694 · 2023: $2,010 · 2024: $2,265 · 2025: $1,942.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,216.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,515.10 | 2019-2025 | Briviact, Nayzilam, Rystiggo |
| Abbvie INC. | $1,499.15 | 2021-2025 | Ubrelvy, Botox, Qulipta |
| Eisai INC. | $607.05 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $492.19 | 2019-2025 | |
| Argenx US, INC. | $470.16 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Alexion Pharmaceuticals, INC. | $427.72 | 2019-2025 | Ultomiris |
| Pfizer INC. | $420.15 | 2023-2025 | |
| Sk Life Science, INC. | $340.17 | 2020-2025 | |
| Lundbeck LLC | $332.59 | 2023-2025 | Vyepti, Rexulti |
| Biogen, INC. | $318.17 | 2019-2025 | Vumerity, Leqembi, Avonex |
| Amgen INC. | $312.72 | 2020-2025 | Uplizna |
| Adamas Pharmaceuticals, INC. | $288.18 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $258.82 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $228.18 | 2019-2025 | Austedo Xr, Austedo Xr |
| Scilex Pharmaceuticals INC. | $198.79 | 2019-2025 | Ztlido |
Show all 65 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Baez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.